A novel BLK-induced tumor model

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

(2016) L Ratner et al.   Blood Cancer Journal

B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

(2014) D L Petersen et al.   LEUKEMIA

NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins

(2013) K. De Keersmaecker et al.   HAEMATOLOGICA

LCK Is an Important Mediator of B-Cell Receptor Signaling in Chronic Lymphocytic Leukemia Cells

(2013) Fatima Talab et al.   MOLECULAR CANCER RESEARCH

BANK1 and BLK Act through Phospholipase C Gamma 2 in B-Cell Signaling

(2013) Manuel Bernal-Quirós et al.   PLoS One

A Meta-Analysis of Gene Expression Data Identifies a Molecular Signature Characteristic for Tumor-Stage Mycosis Fungoides

(2012) Marloes S. van Kester et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Expression of RUNX1 isoforms and its target gene BLK in childhood acute lymphoblastic leukemia

(2012) Oreth Montero-Ruíz et al.   LEUKEMIA RESEARCH

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

(2012) Jordi Barretina et al.   NATURE

The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells

(2012) Haojian Zhang et al.   NATURE GENETICS

Dasatinib

(2011) Paul L. McCormack et al.   DRUGS

Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma

(2009) T. Krejsgaard et al.   BLOOD

FYNis overexpressed in human prostate cancer

(2008) Edwin M. Posadas et al.   BJU INTERNATIONAL

Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma

(2008) H. Guan et al.   MOLECULAR CANCER THERAPEUTICS

Src family kinases: Regulation of their activities, levels and identification of new pathways

(2007) Evan Ingley   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS